Biotech Values

[ghmm]

QURE:

IMO No! It likely explains the rise 2 days ago though! The positive potential in going to the Padua modification (which is what ONCE did with a different vector though) is much better news then the Q3 start (if one paid attention closely and read between the lines they said about bleeds as an end point and one could postulate this would be prospective and of significant duration).

I think the stock should be up on today's news (perhaps significantly). Management has done a poor job and made many poor decisions and not explained themselves well there are risks with this but this is probably the best decision they've done since I've owned them. The program was going to be dead IMO otherwise (more because of timeline then limited efficacy).